Daytrana FDA Approved Drugs
COTEMPLA XR-ODT [MethylphenidateC14H19NO2]
RX
- 17.3mg (oral tablet, orally disintegrating, extended release)
25.9mg (oral tablet, orally disintegrating, extended release)
8.6mg (oral tablet, orally disintegrating, extended release)
Neos Theraps IncJun 19, 2017
DAYTRANA [MethylphenidateC14H19NO2]
RX
- 10mg/9hr (1.1mg/hr) (transdermal film, extended release)
15mg/9hr (1.6mg/hr) (transdermal film, extended release)
20mg/9hr (2.2mg/hr) (transdermal film, extended release)
30mg/9hr (3.3mg/hr) (transdermal film, extended release)
Noven Pharms IncApr 6, 2006
- For the treatment of attention deficit hyperactivity disorder (adhd).
- Method for transdermally delivering a drug to a user in need thereof.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.